Steve Nicholls
@ProfSNicholls
Followers
3K
Following
5K
Media
148
Statuses
4K
absent dad and husband, sports fan, political junkie, cardiologist, researcher, hospital builder, runner and bad golfer. President CSANZ
Joined April 2012
Congrats to @AshishSarraju on your leadership of TANDEM and your contribution to the obicetrapib story
Exciting day with more obicetrapib data for at @society_eas with publications in @NEJM and @TheLancet @JohnKastelein @ProfKausikRay @mdavidsonmd @ajnelson @julie_butters @MonashVHI @NewAmsPharma
2
4
34
Exciting day with more obicetrapib data for at @society_eas with publications in @NEJM and @TheLancet @JohnKastelein @ProfKausikRay @mdavidsonmd @ajnelson @julie_butters @MonashVHI @NewAmsPharma
3
27
111
Exciting day with more obicetrapib data for at @society_eas with publications in @NEJM and @TheLancet @JohnKastelein @ProfKausikRay @mdavidsonmd @ajnelson @julie_butters @MonashVHI @NewAmsPharma
3
27
111
Simon Toussaint was playing cricket when he went to sit down as he thought he had reflux. Moments later he went into cardiac arrest. He’s lucky for what happened next. | @theheraldsun
@MonashVHI @MonashHealth @MonashUni @ProfSNicholls
https://t.co/EaHokZ1T03
0
1
11
Simon thought he had reflux, minutes later he nearly died https://t.co/Mxkl5I6B4Y Great piece on our home and incredible team. Thanks @rileyrobyn08 @MonashVHI @MonashHealth @MonashUni
1
2
10
We are accepting applications for our 1 year clinical and research preventive cardiology fellowship at Baylor College of Medicine- great experience for IM residents interested in prevention @CBallantyneMD @BCMHeart @CardioNerds @ASPCardio
0
3
19
STAREE, the largest statin trial in people aged ≥70, will evaluate the impact of atorvastatin on CV events and disability-free survival in a cohort of nearly 10K community-dwelling participants. #AHAJournals @PZoungas @ProfSNicholls @Monash_SPHPM
https://t.co/TyAee1FyHA
0
2
12
It was a privilege to present the findings of the KRAKEN and BROOKLYN trials at #AHA24 today on behalf of two incredible teams and the patients who play an important role in advancing treatments for heart disease @MonashVHI @NewAmsPharma @EliLillyandCo
5
17
91
The European Atherosclerosis Society @society_eas seeks nominations for the 2025 Anitschkow Prize, the highest honor awarded for research in the area of atherosclerosis and linked metabolic disturbances 👇 https://t.co/huoYCxDmER
0
9
30
Great to see @MonashHeart director Derek Chew present a late breaker at #ESC2024 embedding AI to assist risk prediction and triage to treatment in the ED. Small steps into a new frontier of patient care. @MonashVHI
1
11
71
Excited to launch @TheLancet Commission on Finding Solutions for the Cardiovascular Disease Burden in the Asia Pacific Region with my good friend @lamcardio - a lot of work lies ahead with energetic colleagues @richardhorton1 @dukenus @MonashVHI
8
11
103
Thank you to the whole @thecsanz community - it’s been fun and hopefully we’ve laid the foundation for great things. Thank you for the privilege of being President. It’s been a great honour. The future is in great hands with @lund_mayanna
Life is a series of #handoffs @lund_mayanna recognises the service and achievements of @ProfSNicholls and sets her agenda for a diverse and inclusive @thecsanz #TheFutureIsBright Thanks to @ProfSNicholls
4
8
85
Time to harness the incredible potential of clinicians, researchers, health services and governments across the Asia Pacific region to tackle this high burden disease @JAMA_current @lamcardio @ajnelson @MonashVHI
Viewpoint from @ProfSNicholls, @lamcardio, and Adam Nelson discusses the potential challenges to the operational conduct of clinical trials in the Asia-Pacific region, where there is a high rate of cardiovascular disease. https://t.co/BVb0rnSyMw
0
18
64
Enormous impact of his research
nytimes.com
The Japanese biochemist found in the 1970s that cholesterol-lowering drugs lowered the level of LDL, or “bad” cholesterol, in the blood.
0
0
7
Great to see the early work leading to muvalaplin in press @Nature today - early findings of Lp(a) reduction, more work to do @EliLillyandCo @MonashVHI
1
9
66
We’re excited to have @aphrs2024 in Sydney this year @thecsanz
Fantastic submissions so far but we have had so many requests for an extension - here you go……but, get your manuscripts ready - we want as many as possible to be simultaneously published - improve your A:M ratio @drjohnm @nmarrouche @leftbundle @PrashSanders @jodieingles27
0
6
26
Fantastic submissions so far but we have had so many requests for an extension - here you go……but, get your manuscripts ready - we want as many as possible to be simultaneously published - improve your A:M ratio @drjohnm @nmarrouche @leftbundle @PrashSanders @jodieingles27
0
7
8
Busy week sharing news of apoA-I @NEJM, zerlasiran @JAMA_current, plozasiran @JAMACardio, bempedoic acid, solbinsiran and @worldheartfed cafe at #ACC24 - innovation in prevention @MonashVHI @MonashHealth Welcome colleagues at @ACCinTouch convocation @Drroxmehran @thecsanz
2
4
58
Real benefit for patients
Continued rilonacept treatment reduces the risk of pericarditis recurrence by 98% beyond 18 months of treatment. #AHAJournals @ImazioMassimo @AbbateAntonio @BasilLewis18 @ProfSNicholls
https://t.co/8y3Xcu1zUF
0
5
29